Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 59

    1.

    Modulation of Advanced Glycation End Products by Candesartan in Patients with Diabetic Kidney Disease-A Dose-Response Relationship Study.

    Saha SA, Lasalle BK, Clifton GD, Short RA, Tuttle KR.

    Am J Ther. 2009 Oct 13. [Epub ahead of print]PMID: 19829095 [PubMed - as supplied by publisher]Related articles

    2.

    Can comprehensive lifestyle change alter the course of chronic kidney disease?

    Tuttle KR, Sunwold D, Kramer H.

    Semin Nephrol. 2009 Sep;29(5):512-23.PMID: 19751897 [PubMed - in process]Related articles

    3.

    Should albuminuria be a focus of antihypertensive therapy goals?

    Alicic RZ, Saha SA, Short RA, Tuttle KR.

    Curr Hypertens Rep. 2009 Oct;11(5):354-62.PMID: 19737452 [PubMed - in process]Related articles

    4.

    The "Eco-Atkins" diet: new twist on an old tale.

    Tuttle KR, Milton JE.

    Arch Intern Med. 2009 Jun 8;169(11):1027. No abstract available. PMID: 19506171 [PubMed - indexed for MEDLINE]Related articles

    5.

    Obesity management in adults with CKD.

    Kramer H, Tuttle KR, Leehey D, Luke A, Durazo-Arvizu R, Shoham D, Cooper R, Beddhu S.

    Am J Kidney Dis. 2009 Jan;53(1):151-65. Review. No abstract available. PMID: 19101399 [PubMed - indexed for MEDLINE]Related articles

    6.

    More is not always better: intensive glycemic control in type 2 diabetes.

    Tuttle KR.

    Am J Kidney Dis. 2009 Jan;53(1):12-5. No abstract available. PMID: 19101398 [PubMed]Related articles

    7.

    Protein kinase C-beta inhibition for diabetic kidney disease.

    Tuttle KR.

    Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S70-4. Review.PMID: 18977550 [PubMed - indexed for MEDLINE]Related articles

    8.

    Could renin inhibition be the next step forward in the treatment of diabetic kidney disease?

    Tuttle KR.

    Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):20-1. Epub 2008 Oct 7. No abstract available. PMID: 18838970 [PubMed]Related articles

    9.

    Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.

    Tuttle KR, Anderberg RJ, Cooney SK, Meek RL.

    Am J Nephrol. 2009;29(3):171-80. Epub 2008 Sep 8.PMID: 18781061 [PubMed - indexed for MEDLINE]Related articles

    10.

    Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury?

    Ryan MJ, Tuttle KR.

    Curr Opin Nephrol Hypertens. 2008 Sep;17(5):443-9. Review.PMID: 18695383 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial).

    Tuttle KR, Shuler LA, Packard DP, Milton JE, Daratha KB, Bibus DM, Short RA.

    Am J Cardiol. 2008 Jun 1;101(11):1523-30. Epub 2008 Mar 26.PMID: 18489927 [PubMed - indexed for MEDLINE]Related articles

    12.

    Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?

    Alicic R, Tuttle KR.

    Curr Hypertens Rep. 2007 Nov;9(5):393-402. Review.PMID: 18177587 [PubMed - indexed for MEDLINE]Related articles

    13.

    Albuminuria reduction: the holy grail for kidney protection.

    Tuttle KR.

    Kidney Int. 2007 Oct;72(7):785-6.PMID: 17882241 [PubMed - indexed for MEDLINE]Related articles

    14.

    Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.

    Tuttle KR, McGill JB, Haney DJ, Lin TE, Anderson PW; PKC-DRS, PKC-DMES, and PKC-DRS 2 Study Groups.

    Clin J Am Soc Nephrol. 2007 Jul;2(4):631-6. Epub 2007 May 30.PMID: 17699475 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Advanced glycation end products and nephrotoxicity of high-protein diets.

    Uribarri J, Tuttle KR.

    Clin J Am Soc Nephrol. 2006 Nov;1(6):1293-9. Epub 2006 Sep 27. Review.PMID: 17699361 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy.

    Anderson PW, McGill JB, Tuttle KR.

    Curr Opin Nephrol Hypertens. 2007 Sep;16(5):397-402. Review.PMID: 17693752 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.

    Gilbert RE, Kim SA, Tuttle KR, Bakris GL, Toto RD, McGill JB, Haney DJ, Kelly DJ, Anderson PW.

    Diabetes Care. 2007 Apr;30(4):995-6. Epub 2007 Jan 17. No abstract available. PMID: 17229944 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD.

    Nelson RG, Tuttle KR.

    Blood Purif. 2007;25(1):112-4. Epub 2006 Dec 14.PMID: 17170547 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.

    Nakagawa T, Tuttle KR, Short RA, Johnson RJ.

    Nat Clin Pract Nephrol. 2005 Dec;1(2):80-6. Review.PMID: 16932373 [PubMed - indexed for MEDLINE]Related articles

    20.

    NKF releases new KDOQI guidelines for diabetes and CKD.

    Nelson RG, Tuttle KR.

    Nephrol News Issues. 2006 Jul;20(8):29. No abstract available. PMID: 16859230 [PubMed - indexed for MEDLINE]Related articles

    21.

    Implications of chronic kidney disease for dietary treatment in cardiovascular disease.

    Packard DP, Milton JE, Shuler LA, Short RA, Tuttle KR.

    J Ren Nutr. 2006 Jul;16(3):259-68. Review.PMID: 16825032 [PubMed - indexed for MEDLINE]Related articles

    22.

    The effect of ruboxistaurin on nephropathy in type 2 diabetes.

    Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW.

    Diabetes Care. 2005 Nov;28(11):2686-90.PMID: 16249540 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    A causal role for uric acid in fructose-induced metabolic syndrome.

    Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ.

    Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31. Epub 2005 Oct 18.PMID: 16234313 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease.

    Tuttle KR.

    J Am Soc Nephrol. 2005 Jun;16(6):1537-8. Epub 2005 May 4. No abstract available. PMID: 15872083 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    The next generation of diabetic nephropathy therapies: an update.

    Williams ME, Tuttle KR.

    Adv Chronic Kidney Dis. 2005 Apr;12(2):212-22. Review.PMID: 15822057 [PubMed - indexed for MEDLINE]Related articles

    26.

    Renal manifestations of the metabolic syndrome.

    Tuttle KR.

    Nephrol Dial Transplant. 2005 May;20(5):861-4. Epub 2005 Mar 15. No abstract available. PMID: 15769811 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Uric acid, microalbuminuria and cardiovascular events in high-risk patients.

    Short RA, Johnson RJ, Tuttle KR.

    Am J Nephrol. 2005 Jan-Feb;25(1):36-44. Epub 2005 Feb 21.PMID: 15724081 [PubMed - indexed for MEDLINE]Related articles

    28.

    Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C.

    Tuttle KR, Johnson EC, Cooney SK, Anderberg RJ, Johnson EK, Clifton GD, Meek RL.

    Kidney Int. 2005 Mar;67(3):953-68.PMID: 15698434 [PubMed - indexed for MEDLINE]Related articles

    29.

    Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective.

    Short RA, Tuttle KR.

    Semin Nephrol. 2005 Jan;25(1):25-31. Review.PMID: 15660331 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cardiovascular implications of albuminuria.

    Tuttle KR.

    J Clin Hypertens (Greenwich). 2004 Nov;6(11 Suppl 3):13-7. Review.PMID: 15538106 [PubMed - indexed for MEDLINE]Related articles

    31.

    Atherosclerotic renal artery stenosis: current status and future directions.

    Zalunardo N, Tuttle KR.

    Curr Opin Nephrol Hypertens. 2004 Nov;13(6):613-21. Review.PMID: 15483451 [PubMed - indexed for MEDLINE]Related articles

    32.

    Diabetic nephropathy: implications for renal and cardiovascular outcomes.

    Folan LA, Tuttle KR.

    Minerva Med. 2004 Oct;95(5):385-94. Review.PMID: 15467514 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Quiz page. Primary hyperparathyroidism.

    Tuttle KR, Lewis TH, Kohlmeier LA.

    Am J Kidney Dis. 2004 May;43(5):A49, e1-3. No abstract available. PMID: 15112190 [PubMed - indexed for MEDLINE]Related articles

    34.

    A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

    Tuttle KR, Anderson PW.

    Am J Kidney Dis. 2003 Sep;42(3):456-65. Review.PMID: 12955673 [PubMed - indexed for MEDLINE]Related articles

    35.

    Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

    Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M.

    Hypertension. 2003 Jun;41(6):1183-90. Epub 2003 Apr 21. Review.PMID: 12707287 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Amino acids induce indicators of response to injury in glomerular mesangial cells.

    Meek RL, Cooney SK, Flynn SD, Chouinard RF, Poczatek MH, Murphy-Ullrich JE, Tuttle KR.

    Am J Physiol Renal Physiol. 2003 Jul;285(1):F79-86. Epub 2003 Mar 18.PMID: 12644443 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Predictors of ARF after cardiac surgical procedures.

    Tuttle KR, Worrall NK, Dahlstrom LR, Nandagopal R, Kausz AT, Davis CL.

    Am J Kidney Dis. 2003 Jan;41(1):76-83.PMID: 12500223 [PubMed - indexed for MEDLINE]Related articles

    38.

    Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosis.

    Tuttle KR.

    Am J Kidney Dis. 2002 Jun;39(6):1321-2. No abstract available. PMID: 12046050 [PubMed - indexed for MEDLINE]Related articles

    39.

    Effects of amino acids and glucose on mesangial cell aminopeptidase a and angiotensin receptors.

    Chouinard RF, Meek RL, Cooney SK, Tuttle KR.

    Kidney Int. 2002 Jan;61(1 Suppl):S106-9.PMID: 11841622 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes.

    Tuttle KR, Puhlman ME, Cooney SK, Short RA.

    Am J Physiol Renal Physiol. 2002 Jan;282(1):F103-12.PMID: 11739118 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Sex differences in uric acid and risk factors for coronary artery disease.

    Tuttle KR, Short RA, Johnson RJ.

    Am J Cardiol. 2001 Jun 15;87(12):1411-4. No abstract available. PMID: 11397367 [PubMed - indexed for MEDLINE]Related articles

    42.

    Ischemic nephropathy.

    Tuttle KR.

    Curr Opin Nephrol Hypertens. 2001 Mar;10(2):167-73. Review.PMID: 11224690 [PubMed - indexed for MEDLINE]Related articles

    43.

    Toward more rational management of ischemic nephropathy: the need for clinical evidence.

    Tuttle KR.

    Am J Kidney Dis. 2000 Oct;36(4):863-5. No abstract available. PMID: 11007693 [PubMed - indexed for MEDLINE]Related articles

    44.

    Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease.

    Johnson RJ, Tuttle KR.

    Hypertension. 2000 Mar;35(3):E10. No abstract available. PMID: 10720608 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study.

    Tuttle KR, Puhlman ME, Cooney SK, Short R.

    Am J Kidney Dis. 1999 Nov;34(5):918-25.PMID: 10561150 [PubMed - indexed for MEDLINE]Related articles

    46.

    Endovascular stents for renal artery revascularization.

    Tuttle KR, Raabe RD.

    Curr Opin Nephrol Hypertens. 1998 Nov;7(6):695-701. Review.PMID: 9864668 [PubMed - indexed for MEDLINE]Related articles

    47.

    Screening for renal artery stenosis: hypertension and more...

    Tuttle KR.

    Am J Kidney Dis. 1998 Nov;32(5):842-5; discussion 845-7. No abstract available. PMID: 9820458 [PubMed - indexed for MEDLINE]Related articles

    48.

    Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent.

    Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR, Short RA, Henneberry KJ, Dunham LA, Raabe RD.

    Am J Kidney Dis. 1998 Oct;32(4):611-22.PMID: 9774123 [PubMed - indexed for MEDLINE]Related articles

    49.

    Diabetic nephropathy.

    Castellino P, Giordano M, Tuttle KR.

    Curr Ther Endocrinol Metab. 1997;6:465-75. Review. No abstract available. PMID: 9174791 [PubMed - indexed for MEDLINE]Related articles

    50.

    Diabetic nephropathy.

    Castellino P, Tuttle KR, DeFronzo RA.

    Curr Ther Endocrinol Metab. 1994;5:426-36. No abstract available. PMID: 7704768 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...